Provided By PR Newswire
Last update: Jan 29, 2025
NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. ("Atara" or the "Company") (NASDAQ: ATRA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:ATRA (5/2/2025, 8:00:01 PM)
7.82
+0.26 (+3.44%)
Find more stocks in the Stock Screener